Cedecea species are recent members of the family Enterobacteriaceae and are rarely incriminated in human infections. A patient with protracted urinary tract infection, post-prostatectomy, was referred to Lahor Research Laboratories, Benin City, Nigeria for routine culture and susceptibility testing. Three consecutive mid-stream urine samples from him yielded pure, heavy, growths of an apparently same Gram negative, nonspore forming, non-capsulated, motile, rod-shaped bacterium, which was lipase, citrate, methyl red, KCN, ONPG, arginine and ornithine decarboxylase positive. It was oxidase, urease, H 2 S, indole, gelatinase, deoxyribonuclease and phenylalanine deaminase negative. It fermented glucose, xylose, sucrose, salicin, maltose mannitol, and lactose but was negative arabinose, inositol, dulcitol, raffinose, rhamnose and melibiose. It exhibited multiple antibiotic resistances to augmentin, gentamicin, ofloxacin, cefixime, ciprofloxacin, ceftazidime and cefuroxime but was very sensitive to imipenem and moderately susceptible to nitrofurantoin. The isolate was identified phylogenetically as Cedecea davisae. It possessed plasmid at 48.5 kb and harboured SHV, TEM, and gyrA antibiotic-resistance genes, which were either plasmid-mediated, chromosomal-mediated or both. To the best of knowledge, this is the first report on the incrimination of this organism with human infection in Nigeria. It was concluded that the paucity of reports on Cedecea species as aetiologic agents of human infections could be as a result of the difficulty in recognizing and characterizing this recently described pathogen, particularly in low resource laboratories, coupled with the fact that Laboratorians and Physicians are yet to be fully aware of the emerging clinical significance of this "relatively new" organism.
INTRODUCTION
The genus Cedecea is a relatively new member of the family Enterobacteriacea and its name is an abbreviation for the Centers for Disease Control (CDC), where the initial group of isolates, "Enteric Group 15", were first discovered (Michael and Abbatt, 2006) . Five species are currently believed to be members of the genus, three of which, Cedecea davisae, C. lapagei and C. neteri, have so far been fully identified (Dalamago and Vrioni, 2011) .
They are Gram negative, oxidase negative, lipase positive, non-sporulating motile rod-shaped bacteria. A literature search reveals that there are limited reports that have incriminated Cedecea spp. as human pathogens. Members of the genus have been isolated from human clinical specimens including urine (Cekin et al., 2014) , blood (Dalamago et al., 2008a; Dalamago et al., 2008b; Abate et al., 2011; Akinosoglou et al., 2012; Peretz et al., 2013; ) , Ulcer (Dalamago et al., 2008b , Mawardi et al., 2010 Biswal and Hussan, 2015) , sputum (Yetkin et al., 2008; Bozkurt, 2014) .
As a result of the few available reports, coupled with the relatively recent description of the genus, most clinical microbiologists, pathologists, laboratory scientists and other laboratory diagnosticians may be slow to recognize the emerging clinical significance of this genus. From an otherwise routine referral, this report presents the isolation and characterization of an unfamiliar bacterium, identified as Cedecea davisae from urine specimens of a 76 years old post-prostatectomy patient.
MATERIALS AND METHODS Urine bacteriology
A total of four clean-catch mid-stream urine specimens, one on each visit, were collected from the patient and were aseptically inoculated onto Cysteine Lactose Electrolyte Deficient (CLED) agar, MacConkey Agar (MCA) and Blood Agar (BA) media and incubated at 37 °C aerobically for 24 hrs. Colonial morphologies on media were observed and the colonies were counted using colony counter. Counts of ≥10 5 per ml were considered as significant growth (Cheesbrough et al., 2006) .
Ethical approval
The urine samples were collected after the necessary routine pre-sampling explanations, prior to securing the patient's understanding and consent. Ethical clearance to publish these findings was obtained from the Ethics Committee of the Lahor Research Laboratories and Medical Centre (Ref. No. LRL/005/035).
Microscopic examination of urine sample
Two loopfuls of uniformly mixed uncentrifuged urine sample were aseptically placed on a clean grease-free slide and covered with a cover slip. It was examined microscopically to detect the presence of pus cell, epithelial cell, red blood cell, yeast cell, crystal cells and cast cells, using 10x and 40 x objectives with denser iris closed sufficiently to give good contrast.
Biochemical characterization of isolate
After overnight incubation, the colonies were morphologically described. Standard identification procedures including Gram staining reaction, motility, lipase, oxidase, urease, sugar fermentation, and indole production tests were carried out on the isolate. IMViC (Indole, Methyl red, VoguesProskauer, and Citrate) tests were also carried out to characterize the uropathogen (Olugbue and Onouha 2011; Ehiaghe et al., 2016) .
Antibiotic susceptibility testing
Antimicrobial susceptibility testing was carried out on the isolate using the KirbyBauer disc diffusion method in accordance with the National Committee for Clinical Laboratory Standards guideline (National Committee for Clinical Laboratory Standards, 2003) . Briefly, colonies were suspended in sterile normal saline and the inoculum density was adjusted to 0.5 McFarland turbidity standards. A sterile cotton wool swab was inserted into the standardized growth suspension, rotated with firm pressure on the inside wall of the test tube to remove excess fluid and then used to swab the surface of a freshly prepared dried Mueller-Hinton agar plate. The antimicrobial discs used included nitrofurantoin (Nit 300 µg), ceftazidime ( 
Molecular assays

DNA extraction from bacteria isolate
Single colony from Nutrient agar plate was inoculated into 3 ml of Laura broth (Miller) and incubated at 37 °C overnight with constant agitation at 120 rpm. Aliquot of 1.5 ml of the overnight culture was transferred into a microcentrifuge tube and centrifuged at 13000 rpm for 3 minutes. The pellet was resuspended in 200 µl of nuclease free water and DNA was extracted using the ZR Fungi/Bacterial DNA MiniPrep (Zymo Research, Irvine, CA) as previously described (Ehiaghe et al., 2013) . Molecular detection of antibiotic resistant genes gyrA, TEM, SHV and aac (3)-II Amplification was carried out using OneTaq one-step PCR mix (catalog No. NEB M0486S), supplied by New England Bio Labs Incorporation (Massachusetts), according to the manufacturer's specification. Forward and reverse primers were used to target gyrA, TEM, SHV and aac (3)-II resistant genes as shown in Table 1 using Applied Biosystem 9700 thermal cycler PCR machine at the Lahor Research Laboratories, Benin City, Nigeria. The PCR was performed in a 25 μl reaction mixture containing 12.5 μl oneTaq one-step reaction master mix (2×), 1.25 μl of each forward primer (20 μM), 1.25 μl of each reverse primer (20 μM), 5 μl of nuclease-free water and 5 μl of the DNA template was then added. The PCR was programmed as initial denaturation at 94 °C for 1 min; denaturation at 94 °C for 15 sec, annealing temperature of the primers are shown in Table 1 for 30 sec; and extension at 72 °C for 1 min, repetition of the denaturation step for 35 cycles; final extension at 72 °C for 5 min and final holding at 4 °C. A total of 10 μl of the amplified PCR products were analyzed on 1.0% agarose gel containing ethidium bromide in 1× Tris EDTA buffer. Electrophoresis was performed at 90 V for 40 mins with the EDVOTEK tetra source electrophoresis machine, Bethesda, USA. The targeted genes were visualized using Wealtec (USA) Dolphin-Doc UV transilluminator and photographed. Molecular weights were calculated using molecular weight standard marker (100-1517).
DNA sequencing of isolate Polymerase chain reaction with 16S rRNA
Amplification and sequencing were done as described by Aka-gbezo et al., (2017) , with the following modifications: PCR amplification of 16S rRNA was carried out using OneTaq one-step PCR mix (catalog No. NEB M0486S), supplied by New England Bio Labs Incorporation (Massachusetts), according to the manufacturer's specification. Forward and reverse primers were used to target 16s bacterial rRNA as shown in Table  1 , using Aplied Biosystem 9700 thermal cycler PCR machine. The PCR was carried out, electrophoresis performed and targeted genes visualized as described above.
PCR product cleaning and purification
The PCR products were cleaned using Exo/SAP. Exo/SAP Master mix was prepared by adding 50.0 µl Exonuclease I (NEB M0293) 20 U/ul and 200.0 µl Shrimp Alkaline Phosphatase (NEB M0371) 1U/ul in a 0.6 ml microcentrifuge tube. Exo/SAP Mix of 2.5 µl was then added to 10.0 µl of PCR Mixture, mixed well and was incubated at 37 °C for 30 minutes after which the reaction was stopped by heating at 95 °C for 5 minutes. Purification was done with the ABI V3.1 Big dye kit according to manufacturer's instructions. The labeled products were then cleaned with the Zymo Seq clean-up kit. Sequencing Binding Buffer of 240 μl was added to 20 μl sequencing reaction which was the transferred to a Zymo-Spin™ IB-96 plate mounted onto a collection plate. The mixture was centrifuge at 3,000 x g for 2 minutes. Sequencing Wash Buffer of 300 μl was added to each well of the plate and centrifuge at 3,000 x g for 5minutes. 15 μl of water was directly added to the column matrix of the filter plate. The ZymoSpin™ IB-96 plate was placed on top of the supplied 96-Well PCR plate and mount the assembly onto the Collection Plate which was then centrifuge at 3,000 x g for 2 minutes to elute the DNA.
Sequencing
The Ultra-pure DNA was sequenced with ABI3500XL analyzer with a 50 cm array, using POP7 at Inqaba Biotechnical Industries Ltd (Hatfield, South Africa). Sequences data generated were analyzed with Geneious version 9.0.5 and phylogenetic tree were constructed using neighbor joining.
Plasmid
DNA extraction and documentation
Pure Plasmid DNA isolation was carried out using a commercial plasmid isolation kit (ZR Plasmid Miniprep TM -Classic with Catalog Number D4O15) in accordance with the manufacturer's recommendation, following previously described procedures (Ehiaghe et al., 2016) . Eight microliter extracted plasmids DNA and 2 μl DNA loading dye were separated on a 0.8% agarose gel in tris-borate-EDTA buffer (TBEx1) (pH 8.2) stained with ethidium bromide. Electrophoresis was performed at 90 V for 60 mins with the EDVOTEK tetra source electrophoresis machine, Bethesda, USA. Plasmids were visualized using Wealtec (USA) Dolphin-Doc UV trans-illuminator and photographed. Molecular weights were calculated using molecular weight standard marker (500-48500 bp).
Plasmid DNA curing
In order to ascertain the possible genetic basis of the multiple drug resistance exhibited by the isolate, we carried out plasmid DNA curing analysis as earlier described (Ehiaghe et al., 2016) . In summary, freshly prepared nutrient broth (9 ml) was inoculated with 1 ml overnight culture that was grown in Luria broth (Miller) containing antibiotics for 24 hours at 37 o C. The resultant mixture was incubated for 4 hours to allow for minimal growth of the microorganisms. Aliquot of 1 ml of the 10% sodium dodecyl sulphate curing agent was added to 9 ml nutrient broth culture, and was incubated at 37 o C for 24 hours. The cured culture of 1 ml was inoculated unto 9 ml freshly prepared nutrient broth and incubated at 37 o C for 24 hours. The overnight broth culture was then used to carry out post-curing susceptibility test on MullerHinton agar plate with the necessary antibiotic discs placed and incubated for 24 hours at 37 o C. 
RESULTS
Morphological and biochemical characteristics of the isolate
Pure mucoid, pinkish (lactosefermenting) colonies were observed on MacConkey agar (Plate 1A). The isolate (2-3mm diameter) was non-haemolytic on blood agar. All 3 strains of the isolate were typically Gram negative, motile rod-shaped bacteria, which were lipase positive but oxidase, gelatinase, deoxyribonuclease, indole and urease negative. They utilized citrate as sole source of carbon and were H 2 S, methyl red, arginine, and ornithine decarboxylase positive. They produced acid and gas from glucose, lactose, sucrose, maltose, xylose, trehalose and cellobiose but were negative dulcitol, inositol, sorbitol, adonitol, arabinose, raffinose and melibiose. They did not hyderolize gelatin and deoxyribonucleic acid (Table 2) .
Susceptibility profile of strains
The antibiotic susceptibility profile showed that the three bacteria strains isolated were highly susceptible to imipenem and moderately sensitive to nitrofurantoin but resistant to all other antibiotics used (Plate 1B and Table 3 ).
Plasmid profiling/curing
As shown in Plate 3, the plasmid profile of the isolate revealed that strains U, U2, U3 were positive for plasmid DNA with each band at 48.5kb. The susceptibility patterns of the three strains remained the same post-plasmid curing as shown in Table 3 .
Molecular detection of gyrA, SHV, TEM and aac(3)-II resistance genes on plasmid DNA and genomic DNA extracts
The study revealed that the isolate expressed gyrA resistance gene with bands at 342 and 400 bp for both plasmid DNA and genomic DNA. TEM resistance gene was positive with band at 477 bp for genomic DNA but negative for plasmid DNA. SHV resistance gene was positive at 477 bp for plasmid DNA but negative genomic DNA. However, aac(3)-II resistance gene was negative for both plasmid and genomic DNA (Plates 2 and 4).
Molecular identification of isolate
Analysis of sequence data using Geneious package (version 9.0.5) with Maff alignment revealed that the isolate is closely related to Cedecae davisae as shown in the phylogenetic tree (Figure 1) .
A B
Plate 1 (A & B):
Colonies and antibiogram respectively of a multidrug resistant Cedecea davisae isolated from a 76-year old man with post-prostatectomy UTI. The isolate is highly sensitive to imipenem (IMP), moderately sensitive to nitrofurantoin (NIT) and resistant to the other antibiotics. 
imipenem (IMP) and ceftriaxone (CTX).
Plate 2: Polymerase chain reaction result of antibiotic resistance genes harboured by Cedecea davisae isolated from urine specimen analyzed with 1.0% agarose gel electrophoresis stained with ethidium bromide. L is 100bp-1517 bp DNA ladder (molecular marker Plate 3: Plasmid profile of Cedecea davisae isolate analyzed with 0.8% agarose gel electrophoresis stained with ethidium bromide. L is 0.5 kb -48.5 kb DNA ladder (molecular marker). Strains U1, U2 and U3 are positive for plasmid DNA with bands at 48.5 kb. NC is a no plasmid DNA template control.
48.5kb
0.5kb
Plate 4: PCR result of plasmid DNA extracted from Cedecea davisae, analyzed with 1.0% agarose gel electrophoresis and stained with ethidium bromide. L is 100 bp -1517 bp DNA ladder (molecular marker). Lane 1A is positive for ofloxacin (gyrA) resistant gene with double bands at 342 and 400 bp respectively; lane 1B is positive for augmentin (SHV) resistant gene with band at 477 bp while lanes 1C and 1D are negative for augmentin (TEM) resistance gene and gentamicin (aac(3)-II) resistance gene respectively. NC is a no plasmid DNA template control.
Figure 1: Phylogenetic analysis of a bacterium based on the nucleotide sequence of part of the 16S rRNA nucleotide sequence of the Isolate. The phylogenetic tree was constructed by the NeighborJoining method program in the Geneious package (version 9.0.5). The numbers at the forks show the numbers of occurrences of the repetitive groups to the right out of 100 bootstrap samples. Lahor isolate has similar sequence with Cedecea davisae strain CF26 with accession number KX062011.
DISCUSSION:
About 50% of the Cedecea infections so far reported in literature have been ascribed to Cedecea davisae (Dalamaga et al., 2008a; Abate Qureshis and Mazumber, 2011; Mawardi et al., 2013; Peretz et al. 2013; Akinosoglou et al., 2015) . Most of the cases were associated with bacteremia (Dalamago et al., 2008a; Dalamago et al., 2008b; Abate et al., 2011; Akinosoglou et al., 2012; Peretz et al., 2013) . Cedecea spp. rarely cause urinary tract infections and the only reported case so far was due to Cedecea lapagei (Cekin et al., 2014) . The current report is the first time Cedecea davisae is incriminated as aetiologic agent of UTI.
The strains of Cedecea davisae isolated from three consecutive urine specimens from the patient had similar biochemical profile with those earlier described by Michael and Abbatt (Michael and Abbatt, 2006) . They uniformly produced acid and gas from glucose, xylose and sucrose. They were oxidase, indole, H 2 S and urease negative, motile, Gram negative rods, which produced lipase and decarboxylated arginine and ornithine. Based on the above profile, we initially misidentified the isolate as Serratia spp. until our molecular characterization (phylogenetics) results showed that the isolate has similar DNA sequence with Cedecea davisae strain CF26, with accession number KX062011 (Figure 1 ). This is a rarely seen bacterium in clinical laboratories and may be difficult to recognize and characterize, particularly in low-resource laboratories. Moreover, it is conceivable that Laboratorians inadvertently dismiss this rare organism as contaminants in clinical specimens. These may, in part, explain the paucity of reports about the organism in the literature.
The isolate showed very high degree of resistance to antibiotics that are commonly prescribed in our hospitals and clinics in Nigeria. As shown in Table 3 , the organism was sensitive to only imipenem and nitrofurantoin but resistant to all other antibiotics. This is consistent with previous reports that Cedecea davisae infections can be difficult to treat due to antibiotic resistance of the organism (Dalamago et al., 2008a; Dalamago et al., 2008b; Peretz et al., 2013) . For good therapeutic practices and costeffectiveness, it should be mandatory to establish the antibiogram of clinical isolates before commencement of antibiotic treatment of patients.
The isolate was confirmed to harbour some antibiotic resistance genes which were plasmid-mediated, chromosomal-mediated or both. It harboured gyrA resistance gene, which codes for resistance to ofloxacin. This was found on both plasmid and genomic DNA extracts, suggesting that gyrA resistance gene was both plasmid and chromosomal-borne. However, SHV gene, which codes for augmentin resistance (Keith et al., 2014) , was detected only on the plasmid DNA, while TEM resistance gene, which also codes for augmentin resistance, was detected only on the genomic DNA. Interestingly, the isolate failed to express aac(3)-II gene. The gene was neither found on the plasmid DNA nor on the genomic DNA extracts, yet we reported the organism as resistant to gentamicin. This suggests that gentamicin resistance is possibly coded for, by an additional gene or that we erroneously reported the isolate as resistant to the drug, because of the narrow zone of inhibition observed in-vitro (Plate 1B). The above findings however confirm earlier reports that Cedecea davisae could be highly resistant to several antibiotics (Dalamago et al., 2008a and Dalamago et al., 2008b; Peretz et al., 2013) .
It is also pertinent to note that the possession of plasmid, which bears multidrug resistance genes by this organism, suggests that this isolate could transfer its genetic materials to other susceptible bacteria in the same ecosystem. This portends great public health danger, as such a multidrug resistant pathogen could lead to infections that would be similarly difficult to treat.
Conclusion
This report has described the first isolation and characterization of a multidrug resistant Cedecea davisae from a case of recurrent urinary tract infection in a post-prostatectomy patient in Nigeria. Apart from the report where Cedecea lapagei was earlier isolated from urine, this report appears to be the second case of urinary tract infection caused by Cedecea spp. The emerging clinical significance of this hitherto rare organism in human infections is worthy of note.
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